18F-JSS20-183A

N/A

Report date: 2026/03/04 20:01:44

NME

Base Information

Drug Name18F-JSS20-183A

Drug Alias Name18F-JSS20-183A

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionPositron-emission tomography enhancersMicrotubule-associated protein tau modulators

TargetsMicrotubule-associated protein tau

Therapy Area/IndicationsTauopathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Pennsylvania

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pennsylvania

Inactive CompaniesN/A

Active IndicationsTauopathies

Inactive IndicationsN/A

Other Information

ATC CodeN/A